1. Home
  2. CNK vs IRON Comparison

CNK vs IRON Comparison

Compare CNK & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cinemark Holdings Inc Cinemark Holdings Inc.

CNK

Cinemark Holdings Inc Cinemark Holdings Inc.

HOLD

Current Price

$26.88

Market Cap

2.8B

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$67.99

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNK
IRON
Founded
1984
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.0B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
CNK
IRON
Price
$26.88
$67.99
Analyst Decision
Buy
Strong Buy
Analyst Count
10
13
Target Price
$32.90
$101.92
AVG Volume (30 Days)
2.4M
900.7K
Earning Date
05-18-2026
05-29-2026
Dividend Yield
1.38%
N/A
EPS Growth
N/A
N/A
EPS
1.04
N/A
Revenue
$3,115,000,000.00
N/A
Revenue This Year
$10.59
N/A
Revenue Next Year
$3.83
N/A
P/E Ratio
$25.00
N/A
Revenue Growth
2.15
N/A
52 Week Low
$21.60
$30.82
52 Week High
$34.01
$99.50

Technical Indicators

Market Signals
Indicator
CNK
IRON
Relative Strength Index (RSI) 63.60 45.35
Support Level $24.84 $57.45
Resistance Level $27.45 $82.70
Average True Range (ATR) 1.03 6.35
MACD 0.07 -0.02
Stochastic Oscillator 79.39 67.81

Price Performance

Historical Comparison
CNK
IRON

About CNK Cinemark Holdings Inc Cinemark Holdings Inc.

Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: